Emphysema Completed Phase 3 Trials for Basiliximab (DB00074)

Also known as: Bullous emphysema (lung)(pulmonary) / Pulmonary Emphysema / Emphysema pulmonary

IndicationStatusPhase
DBCOND0019688 (Emphysema)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00188825Study Comparing Simulect Plus Standard Immunosuppression to Standard Immunosuppression Alone for the Prevention of Acute Rejection and Bronchiolitis Obliterans in Lung TransplantTreatment